Evaluation based on Arcserve's Ability to Execute and Completeness of Vision
Draper, UT: Arcserve, the world's most experienced provider of backup, recovery, and immutable storage solutions for unified data resilience against ransomware and disasters, announced it has been named a Challenger in the 2023 Gartner Magic Quadrant for Enterprise Backup and Recovery Software Solutions. (August 2023).
Acronis will deliver best-in-class cyber protection to the club via #CyberFit technology delivery partner Tailor Made Technologies (TMT) to protect Southampton FC´s critical data, applications, and systems.
London, UK: Southampton FC has officially announced its renewed partnership with Acronis and Tailor Made Technologies (TMT) today. Under the agreement, TMT will be providing the team with a full suite of Acronis cyber protection solutions to protect the team's data assets and optimise data workflow, facilitating the team to perform at its best both on and off the pitch.
Tool Provides Advanced Insights to Accelerate Passkey Deployment and Optimise User Experience
NEW YORK: Beyond Identity has announced the launch of The Passkey Journey – a free, GDPR-compliant tool built to help development and user experience (UX) teams understand, plan, and optimise different end user authentication experiences. The tool solves key challenges around passkey adoption and offers much needed clarity into the pain of UX inconsistencies across browsers and devices with just a few lines of code.
Integrated drug formulation and clinical trials company, BDD has secured a further round of investment for £2M to aid the company’s expansion in response to growing demand for both its patented drug delivery technology and specialist clinical trial services.
The funding round was led by existing investors including angel syndicate Archangels, Scottish Enterprise, and new investor British Business Bank.
The latest investment package follows a strong 18 months for the company, which more than doubled revenues in 2022 and has already secured substantial contracts with major pharma and biopharmaceutical companies for 2023 and 2024. This investment will allow the business to increase its clinical capacity and expand capabilities to offer the sector the ease and convenience of a single point of contact for early phase formulation development and clinical evaluation.
To expose official corruption in Nigeria, re-orientate the psyche of Nigerians and usher in the Nigerian renaissance
Have you got news/articles for us? We welcome news stories and articles from security experts, intelligence analysts, industry players, security correspondents in the main stream media and our numerous readers across the globe.
Vigilance is the brain child of a group of veteran journalists and international scholars who have worked in the mainstream media and distinguished themselves nationally and internationally before veering into security practice.
We have 243 guests and no members online